Hepatitis: Difference between revisions

Jump to navigation Jump to search
Mmir (talk | contribs)
Category
No edit summary
 
(18 intermediate revisions by 6 users not shown)
Line 1: Line 1:
{|class="infobox mw-collapsible" id="floatvideo" style="position: fixed; top: 65%; width:361px; right: 10px; margin: 0 0 0 0; border: 0; float: right;
| Title
|-
|-
| {{#ev:youtube|https://https://www.youtube.com/watch?v=eocRM7MhF68|350}}
|-
|}
__NOTOC__
__NOTOC__


Line 14: Line 7:


==Overview==
==Overview==
Hepatitis refers to the inflammation of the liver. The etiologic agent could be infectious (almost always viral) or non-infectious. Depending on the disease course various kinds of hepatitis may be classified as acute or chronic. Acute viral hepatitis is a spectrum of systemic inflammatory conditions that predominantly involves the liver. [[Hepatitis A virus]] (HAV), [[hepatitis B virus]] (HBV), [[hepatitis C virus]] (HCV), the HBV-associated delta agent or [[Hepatitis D Virus|hepatitis D virus]] (HDV), and [[hepatitis E virus]] (HEV) are the most common viruses that may cause acute viral hepatitis. [[Alcoholic hepatitis]] and and [[Non-alcoholic fatty liver disease|non alcoholic steatohepatitis]] (NASH) are the most common non-infectious types of hepatitis. Many drugs and toxins may also result in hepatic injury. The common manifestation among the patients of hepatitis are [[fever]], [[jaundice]], [[fatigue]], [[abdominal pain]], and [[hepatomegaly]]. Diagnosis of hepatitis is based on the clinical manifestations and laboratory findings. In rare conditions [[liver biopsy]] is required for either the diagnosis or formulating a treatment plan. In some cases disease may become chronic and result in multiple complications such as, [[hepatocellular carcinoma]] (HCC), [[cirrhosis]], or [[hepatorenal syndrome]]. In such conditions [[liver transplantation]] is the definitive treatment option.
[[Hepatitis, chronic autoimmune|Hepatitis]] refers to the inflammation of the liver. The etiologic agent could be infectious (almost always viral) or non-infectious. Hepatitis can be acute and self limiting or can be chronic and progress to cirrhosis or hepatocellular carcinoma (HCC). Most common causes of infectious hepatitis are viral in origin. These include hepatitis A, B, C, D and E . Non infectious causes of hepatitis include autoimmune, alcohol, drugs and toxins. Alcoholic hepatitis and and non alcoholic steatohepatitis (NASH) are the most common non-infectious types of hepatitis.
 
The common manifestation of acute hepatitis are fever, jaundice, fatigue, abdominal pain, and hepatomegaly. Diagnosis of hepatitis is based on the clinical manifestations and laboratory findings. In rare conditions liver biopsy is required for either the diagnosis or formulating a treatment plan.


==Classification==
==Classification==
Hepatitis may be classified depending on the duration of the disease into the following types:
Hepatitis may be classified depending on the duration of the disease into the following types:
*Acute hepatitis
*Acute hepatitis
*Chronic hepatitis
*Chronic hepatitis


Hepatitis may also be classified on the basis of various causes into the following types:
Hepatitis may also be classified on the basis of various causes into the following types:
*Infectious hepatitis
*Infectious hepatitis
*Non-infectious hepatitis
*Non-infectious hepatitis
===Infectious Hepatitis===
===Infectious Hepatitis===
Infectious hepatitis can be classified according to the causative viral agent in to 7 major categories.
Infectious hepatitis can be classified according to the causative viral agent in to 7 major categories.
Line 30: Line 28:
{| align="center"
{| align="center"
|-
|-
|  
|
{{familytree/start}}
{{familytree/start}}
{{familytree | | | | | | | | | | | | | | | A01 | | | | | |A01='''Viral Hepatitis'''}}
{{familytree | | | | | | | | | | | | | | | A01 | | | | | |A01='''Viral Hepatitis'''}}
Line 61: Line 59:
{|
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! colspan="2" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Disease
! colspan="2" rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
! colspan="5" align="center" style="background:#4479BA; color: #FFFFFF;" |Clinical manifestations
! colspan="5" style="background:#4479BA; color: #FFFFFF;" align="center" |Clinical manifestations
! colspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Laboratory findings
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Laboratory findings
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Additional findings
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
|-
|-
! colspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Symptoms
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Symptoms
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Signs
! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Signs
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Transaminitis (elevated AST and ALT)
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Transaminitis (elevated AST and ALT)
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Viral markers
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Viral markers
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Autoimmune markers
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Autoimmune markers
|-
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" |Nausea & vomiting
! style="background:#4479BA; color: #FFFFFF;" align="center" |Nausea & vomiting
! align="center" style="background:#4479BA; color: #FFFFFF;" |Abdominal pain
! style="background:#4479BA; color: #FFFFFF;" align="center" |Abdominal pain
! align="center" style="background:#4479BA; color: #FFFFFF;" |Arthralgia
! style="background:#4479BA; color: #FFFFFF;" align="center" |Arthralgia
! align="center" style="background:#4479BA; color: #FFFFFF;" |Jaundice
! style="background:#4479BA; color: #FFFFFF;" align="center" |Jaundice
! align="center" style="background:#4479BA; color: #FFFFFF;" |Hepatomegaly
! style="background:#4479BA; color: #FFFFFF;" align="center" |Hepatomegaly
|-
|-
| rowspan="6" style="background:#4479BA; color: #FFFFFF" |Acute viral hepatitis
| rowspan="6" style="background:#4479BA; color: #FFFFFF" |Acute viral hepatitis
Line 89: Line 87:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ---
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ---
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Fecal-oral transmission
*Fecal-oral transmission
* Usually acute and self limit
*Usually acute and self limit
* [[Fever]] usually present
*[[Fever]] usually present
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis B]]
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis B]]
Line 103: Line 101:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ---
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ---
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Percutaneous transmission most common  
*Percutaneous transmission most common
* May cause acute hepatic failure  or may become chronic
*May cause acute hepatic failure  or may become chronic
* [[Fever]] usually present
*[[Fever]] usually present
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis C]]
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis C]]
Line 117: Line 115:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Percutaneous transmission is most common
*Percutaneous transmission is most common
* Higher rate of chronic progression
*Higher rate of chronic progression
* Associated with extra hepatic manifestation such as [[cryoglobulinemia]] and [[membranoproliferative glomerulonephritis]]
*Associated with extra hepatic manifestation such as [[cryoglobulinemia]] and [[membranoproliferative glomerulonephritis]]
* [[Fever]] usually present
*[[Fever]] usually present
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis E]]
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis E]]
Line 132: Line 130:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Fecal-oral transmission
*Fecal-oral transmission
* May cause fulminant disease in pregnancy
*May cause fulminant disease in pregnancy
* [[Fever]] usually present
*[[Fever]] usually present
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cytomegalovirus infection natural history, complications and prognosis|CMV hepatitis]]
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cytomegalovirus infection natural history, complications and prognosis|CMV hepatitis]]
Line 146: Line 144:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>--</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>--</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Usually manifests as mononucleosis syndrome
*Usually manifests as mononucleosis syndrome
* [[fever]] usually present
*[[fever]] usually present
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[EBV]] hepatitis
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[EBV]] hepatitis
Line 159: Line 157:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>--</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>--</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Systemic manifestations as mononucleosis syndrome
*Systemic manifestations as mononucleosis syndrome
* Fever usually present
*Fever usually present
|-
|-
| colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Autoimmune hepatitis
| colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Autoimmune hepatitis
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
Line 172: Line 170:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Antinuclear antibodies|ANA]], [[Anti-SM antibody|ASMA]], anti SLA/LP, [[ANCA]], ALKM-1 antibodies
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Antinuclear antibodies|ANA]], [[Anti-SM antibody|ASMA]], anti SLA/LP, [[ANCA]], ALKM-1 antibodies
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Liver biopsy may be required for diagnosis
*Liver biopsy may be required for diagnosis
|-
|-
| colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Alcoholic hepatitis
| colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Alcoholic hepatitis
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+/-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+/-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
Line 184: Line 182:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* History of alcohol intake
*History of alcohol intake
|-
|-
| colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Drug induced hepatitis
| colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Drug induced hepatitis
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+/-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+/-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
Line 196: Line 194:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* May cause either cholestatic or hepatocellular injury
*May cause either cholestatic or hepatocellular injury
|}
|}
==Treatment==
Treatment of [[hepatitis A]] and [[hepatitis E]] is supportive as they are usually self-limited. Chronic hepatitis E is treated with the antiviral ribavirin.
[[Hepatitis B|Hepatitis B infection]] is treated with pegylated interferon alfa or nucleoside analogs (entecavir, tenofovir) based on the clinical picture including ALT and HBV DNA levels and presence or absence of cirrhosis.
Treatment is indicated in chronic [[Hepatitis C]]  infection which is defined as the presence of detectable HCV RNA levels for 6 months. The selection of treatment regimen depends on viral genotype, presence or absence of cirrhosis and other patient factors. Some of the commonly used antiviral regimens include sofosbuvir-velpatasvir,  glecaprevir-pibrentasvir and ledipasvir-sofosbuvir
Acute [[hepatitis D]] has no specific treatment. For chronic hepatitis D infection, treatment is indicated with PEG interferon alfa for patients with detectable HDV RNA, elevated ALT and evidence of active liver disease.
Asymptomatic patients can be monitored for development of active disease.
[[Alcoholic hepatitis]] is generally treated with alcohol abstinence and supportive care in mild to moderate cases. Severe cases are treated with tapering courses of glucocorticoids.
[[Autoimmune hepatitis]] is treated with glucocorticoid mono therapy or combination of glucocorticoid with azathioprine. Treatment decision is based on symptom severity, laboratory and histologic findings.
==Prevention==
'''Hepatitis A'''
* Vaccination especially amongst high-risk individuals who were not vaccinated in childhood. These include IV drug users, Chronic liver disease patients, and Men who have sex with men (MSM).
*  For individuals at risk of both HAV and HBV, the combined vaccine used as a 3-does series is administered.


{{WH}}
{{WH}}
Line 204: Line 223:
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Hepatology]]
[[Category:Hepatology]]
[[Category:Primary care]]
[[Category:Disease]][[Category:Emergency medicine]]
[[Category:Disease]]
[[Category:Primary care]]
[[Category:Up-To-Date]]
[[Category:Hepatology]]
[[Category:Gastroenterology]]
[[Category:Emergency mdicine]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Primary care]]
[[Category:Emergency medicine]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date]]
[[Category:Emergency mdicine]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Hepatology]]
[[Category:Gastroenterology]]

Latest revision as of 14:10, 6 October 2021


For patient information click here.

Hepatitis Main Page

Home

Patient Information

Overview

Classification

Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatitis E
Alcoholic Hepatitis
Autoimmune Hepatitis

Differential Diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2], Usama Talib, BSc, MD [3]

Overview

Hepatitis refers to the inflammation of the liver. The etiologic agent could be infectious (almost always viral) or non-infectious. Hepatitis can be acute and self limiting or can be chronic and progress to cirrhosis or hepatocellular carcinoma (HCC). Most common causes of infectious hepatitis are viral in origin. These include hepatitis A, B, C, D and E . Non infectious causes of hepatitis include autoimmune, alcohol, drugs and toxins. Alcoholic hepatitis and and non alcoholic steatohepatitis (NASH) are the most common non-infectious types of hepatitis.

The common manifestation of acute hepatitis are fever, jaundice, fatigue, abdominal pain, and hepatomegaly. Diagnosis of hepatitis is based on the clinical manifestations and laboratory findings. In rare conditions liver biopsy is required for either the diagnosis or formulating a treatment plan.

Classification

Hepatitis may be classified depending on the duration of the disease into the following types:

  • Acute hepatitis
  • Chronic hepatitis

Hepatitis may also be classified on the basis of various causes into the following types:

  • Infectious hepatitis
  • Non-infectious hepatitis

Infectious Hepatitis

Infectious hepatitis can be classified according to the causative viral agent in to 7 major categories.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Viral Hepatitis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hepatitis A
 
Hepatitis B
 
Hepatitis C
 
Hepatitis D
 
Hepatitis E
 
Hepatitis F
 
Hepatitis G
 
Other
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EBV hepatitis
CMV hepatitis
HSV hepatitis
Coxsackie B virus hepatitis



Non-Infectious Hepatitis



 
 
 
 
 
 
 
 
 
 
 
 
Non-infectious Hepatitis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alcoholic hepatitis
 
Non-alcoholic steatohepatitis (NASH)
 
Alpha 1 antitrypsin deficiency
 
Autoimmune hepatitis
 
Obstructive hepatitis
 
Drug related hepatitis
 
Toxin related hepatitis
 
Ischemic hepatitis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gallstones
Tumors
 
Isoniazid
NSAIDs
•Beta-lactam antibiotics
•Sulfa-containing drugs
HAART
 
Chemicals
 
 
 
 
 



Differential diagnosis

Hepatitis must be differentiated from other conditions that may cause fever, fatigue, nausea and vomiting, and elevated liver enzymes.

Disease Clinical manifestations Laboratory findings Additional findings
Symptoms Signs Transaminitis (elevated AST and ALT) Viral markers Autoimmune markers
Nausea & vomiting Abdominal pain Arthralgia Jaundice Hepatomegaly
Acute viral hepatitis Hepatitis A +++ ++ + +++ + +++ HAV Ab ---
  • Fecal-oral transmission
  • Usually acute and self limit
  • Fever usually present
Hepatitis B +++ ++ ++ +++ + +++ HBs Ag, HBc Ab, HBe Ag ---
  • Percutaneous transmission most common
  • May cause acute hepatic failure or may become chronic
  • Fever usually present
Hepatitis C +++ ++ ++ +++ + +++ HCV Ab ---
Hepatitis E ++ ++ +/- ++ + +++ HEV Ab ---
  • Fecal-oral transmission
  • May cause fulminant disease in pregnancy
  • Fever usually present
CMV hepatitis +/- ++ - + + ++ CMV-specific immunoglobulin (Ig)M antibody --
  • Usually manifests as mononucleosis syndrome
  • fever usually present
EBV hepatitis +/- ++ - +/- + ++ Heterophile antibody test, monospot test --
  • Systemic manifestations as mononucleosis syndrome
  • Fever usually present
Autoimmune hepatitis - + +/- ++ + +++ --- ANA, ASMA, anti SLA/LP, ANCA, ALKM-1 antibodies
  • Liver biopsy may be required for diagnosis
Alcoholic hepatitis +/- + - + - AST>ALT --- ---
  • History of alcohol intake
Drug induced hepatitis +/- + - + + ++ --- ---
  • May cause either cholestatic or hepatocellular injury

Treatment

Treatment of hepatitis A and hepatitis E is supportive as they are usually self-limited. Chronic hepatitis E is treated with the antiviral ribavirin.

Hepatitis B infection is treated with pegylated interferon alfa or nucleoside analogs (entecavir, tenofovir) based on the clinical picture including ALT and HBV DNA levels and presence or absence of cirrhosis.

Treatment is indicated in chronic Hepatitis C infection which is defined as the presence of detectable HCV RNA levels for 6 months. The selection of treatment regimen depends on viral genotype, presence or absence of cirrhosis and other patient factors. Some of the commonly used antiviral regimens include sofosbuvir-velpatasvir, glecaprevir-pibrentasvir and ledipasvir-sofosbuvir

Acute hepatitis D has no specific treatment. For chronic hepatitis D infection, treatment is indicated with PEG interferon alfa for patients with detectable HDV RNA, elevated ALT and evidence of active liver disease. Asymptomatic patients can be monitored for development of active disease.

Alcoholic hepatitis is generally treated with alcohol abstinence and supportive care in mild to moderate cases. Severe cases are treated with tapering courses of glucocorticoids.

Autoimmune hepatitis is treated with glucocorticoid mono therapy or combination of glucocorticoid with azathioprine. Treatment decision is based on symptom severity, laboratory and histologic findings.

Prevention

Hepatitis A

  • Vaccination especially amongst high-risk individuals who were not vaccinated in childhood. These include IV drug users, Chronic liver disease patients, and Men who have sex with men (MSM).
  • For individuals at risk of both HAV and HBV, the combined vaccine used as a 3-does series is administered.


Template:WH Template:WS